BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioLife Solutions, Inc. is a developer, manufacturer, and marketer of bioproduction tools and services for the cell and gene therapy industry.
BioLife Solutions: Profiting From A Powerful Industry Tailwind

BioLife Solutions Adopts New Brand Identity

08:00am, Tuesday, 15'th Jun 2021
BOTHELL, Wash., June 15, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and ser
BOTHELL, Wash., May 19, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and serv
BioLife Solutions, Inc. (BLFS) CEO Mike Rice on Q1 2021 Results - Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 40.00% and 8.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BOTHELL, Wash., May 3, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produ
BOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction pro
HRC vs. BLFS: Which Stock Is the Better Value Option?
BOTHELL, Wash., April 6, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction p
The stock price of BioLife Solutions Inc (NASDAQ: BLFS) increased by over 15% pre-market. This is why it happened.
BioLife Solutions, Inc. (BLFS) CEO Mike Rice on Q4 2020 Results - Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 0.00% and 9.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stoc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE